Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron
2023-06-29 00:21
J&J’s $8.9 Billion Talc Deal Faces Key Test in Oakland Trial
Johnson & Johnson’s first jury trial in nearly two years over allegations that its talc-based baby powder causes
2023-06-01 06:16
Seven & I Board Seen Prevailing Over ValueAct at Annual Meeting
Seven & i Holdings Co. will probably have enough votes to install its proposed slate of directors at
2023-05-24 08:26
Catalent Cuts Annual Forecast More Than Expected, Delays Earnings Report Again
Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal
2023-05-19 22:16
Philips Says Recalled Devices Unlikely to Harm Patient Health
Royal Philips NV said new tests on its recalled sleep apnea products showed the vast majority of the
2023-05-16 14:54
Drug Contractor Catalent Plunges After Annual Guidance Cut, Results Delayed
Catalent Inc. shares traded at their lowest in three years following cuts to its annual financial outlook that
2023-05-09 02:20